Cumulative effect of cytogenetic hits on multiple myeloma relapse after front-line autologous stem cell transplant

被引：0
|
作者：
Baptista, P. [1 ]
Henriques, M. [1 ]
Pardal, A. A. [1 ]
Monteiro, P. [1 ]
Chorao, P. [1 ]
Soares, M. J. [1 ]
Barbosa, A. [1 ]
Gomes, P. [1 ]
Bergantim, R. [1 ]
Aguiar, E. [1 ]
Pires, J. C. [1 ]
Trigo, F. [1 ]
机构：
[1] Ctr Hosp Univ Sao Joao, Porto, Portugal
来源：
BONE MARROW TRANSPLANTATION | 2022年 / 57卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P404
引用
收藏
页码：322 / 322
页数：1
相关论文
共 50 条
  • [1] Relapse with extramedullary disease after front-line autologous stem cell transplant in patients with multiple myeloma
    Jung, S. -H.
    Lee, S. -S.
    Yang, D. -H.
    Ahn, J. -S.
    Kim, Y. -K.
    Kim, H. -J.
    Lee, J. -J.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S509 - S509
  • [2] Polymorphism in ANRIL is associated with relapse in patients with multiple myeloma after autologous stem cell transplant
    Poi, Ming J.
    Li, Junan
    Sborov, Douglas W.
    VanGundy, Zachary
    Cho, Yu Kyoung
    Lamprecht, Misty
    Pichiorri, Flavia
    Phelps, Mitch A.
    Hofmeister, Craig C.
    MOLECULAR CARCINOGENESIS, 2017, 56 (07) : 1722 - 1732
  • [3] Predictors of Survival in Multiple Myeloma Patients after Relapse from a Delayed Autologous Stem Cell Transplant
    Gonsalves, Wilson I.
    Gertz, Morie
    Dispenzieri, Angela
    Lacy, Martha
    Buadi, Francis
    Dingli, David
    Hayman, Suzanne
    Kapoor, Prashant
    Rajkumar, S. Vincent
    Kumar, Shaji
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S137 - S137
  • [4] Single Centre Experience in Treating Newly Diagnosed t(4;14) Multiple Myeloma with and without Planned Front-Line Autologous Stem Cell Transplant
    Chan, Henry Siu Him
    Phillips, Madeline
    Farooki, Sophia
    Rodriguez, Giovanni Piza
    Masih-Khan, Esther
    Chen, Christine
    Kukreti, Vishal
    Prica, Anca
    Tiedemann, Rodger
    Trudel, Suzanne
    Reece, Donna
    BLOOD, 2016, 128 (22)
  • [5] G-CSF instead of autologous stem cell transplantation after high dose melphalan as front-line therapy in multiple myeloma.
    Harousseau, JL
    Facon, T
    Maloisel, F
    DabouzHarrouche, F
    Witz, F
    Guilhot, F
    Archimbaud, E
    Desablens, B
    Abgrall, JF
    Linassier, C
    Grosbois, B
    Bancillon, A
    Badri, N
    Bataille, R
    BLOOD, 1995, 86 (10) : 725 - 725
  • [6] Complete response after autologous stem cell transplant in multiple myeloma
    Kumar, Lalit
    Iqbal, Nida
    Mookerjee, Anjali
    Verma, Rakesh Kumar
    Sharma, Om D.
    Batra, Atul
    Pramanik, Raja
    Gupta, Ritu
    CANCER MEDICINE, 2014, 3 (04): : 939 - 946
  • [7] Management of Relapsed Multiple Myeloma after Autologous Stem Cell Transplant
    Holstein, Sarah A.
    Richardson, Paul G.
    Laubach, Jacob P.
    McCarthy, Philip L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (05) : 793 - 798
  • [8] Patterns of relapse of multiple myeloma (MM) after autologous stem cell transplantation
    Rio, B
    Hunault, M
    Mignot, L
    Zittoun, R
    Baumelou, E
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 345 - 345
  • [9] Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma
    Chu, Tan-Huy
    Jung, Sung-Hoon
    Kim, Kihyun
    Lee, Jae Hoon
    Mun, Yeung-Chul
    Bang, Soo-Mee
    Yoon, Dok Hyun
    Lee, Ho Sup
    Min, Chang-Ki
    Lee, Je-Jung
    ANNALS OF HEMATOLOGY, 2022, 101 (06) : 1217 - 1226
  • [10] Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma
    Jung, Sung-Hoon
    Chu, Tan-Huy
    Kim, Kihyun
    Lee, Jae Hoon
    Mun, Yeung-Chul
    Bang, Soo-Mee
    Yoon, Dok Hyun
    Min, Chang-Ki
    Lee, Ho Sup
    Lee, Je-Jung
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S99 - S99
12345